HEALTH● LOWSep 2 · Sep 2, 2026, 9:15 PM
INVENTIVA : Inventiva Announces Last Patient Visit in NATiV3 Phase 3 Clinical Trial of Lanifibranor in MASH
finanznachrichten.de · Germany · western europe
Inventiva announced the final patient visit in its Phase 3 clinical trial for Lanifibranor, a key development in its research for MASH treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More from Germany
CONFLICT14h agoGermany has stood by Ukraine throughout Russia’s invasion. A trial over the Nord Stream explosions could put Berlin’s unconditional support to the test.Meduza [en]CONFLICT15h agoNord Stream trial opens in Germany, defense seeks dismissalDW News [en]POLITICS18h agoGermany's far-right AfD forges a pro-Russia alliance with the BSWDW News [en]DISASTER19h ago3 Indians killed in Germany building fire, murder suspect heldindianexpress · india
More in Health
HEALTH35m agoUCH resident doctors suspend warning strikeVanguard NigeriaHEALTH48m agoKatsina health professionals declare 7-day warning strikePremium TimesHEALTH1h agoPope Leo XIV has 'good night' in hospital after lung surgery, Vatican saysEuroNews [en]HEALTH1h agoWHO Urges Action On Lead Poisoning DangersChannels TV